Gainplan’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,211
Closed -$52.9K 67
2025
Q4
$52.9K Sell
11,211
-199
-2% -$887 0.02% 61
2025
Q3
$54.7K Buy
+11,410
New +$44.9K 0.02% 57
2024
Q2
Sell
-36,010
Closed -$360K 74
2024
Q1
$360K Buy
36,010
+25,455
+241% +$223K 0.17% 42
2023
Q4
$74K Buy
+10,555
New +$70.2K 0.04% 47
2022
Q2
Sell
-11,112
Closed -$232K 47
2022
Q1
$232K Buy
+11,112
New +$242K 0.18% 42

Other funds holding MSOS

Gainplan's MSOS Position: Q1 2026 in Review

Gainplan sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2026, closing a stake of 11,211 shares — an estimated $52.9K sold.

Gainplan first reported a position in MSOS in Q1 2022 and held it in 5 quarters. The position peaked at $360K in Q1 2024. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Gainplan reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2026 after selling out during the quarter.
  • Gainplan sold 11,211 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $52.9K.
  • Gainplan first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and held it in 5 quarters.
  • Gainplan's AdvisorShares Pure US Cannabis ETF position peaked at $360K in Q1 2024.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Gainplan's 13F filing for Q1 2026, filed 8 Apr 2026.